Growth Metrics

Staar Surgical (STAA) Cash from Financing Activities (2016 - 2026)

Staar Surgical's Cash from Financing Activities history spans 17 years, with the latest figure at -$50000.0 for Q1 2026.

  • For Q1 2026, Cash from Financing Activities rose 54.55% year-over-year to -$50000.0; the TTM value through Jan 2026 reached -$4.6 million, down 179.58%, while the annual FY2026 figure was -$4.6 million, 179.58% down from the prior year.
  • Cash from Financing Activities reached -$50000.0 in Q1 2026 per STAA's latest filing, down from $983000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $7.1 million in Q3 2023 to a low of -$4.5 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is $1.1 million, with a median of $630500.0 recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 398.02% in 2024, then tumbled 2885.28% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $202000.0 in 2022, then skyrocketed by 81.68% to $367000.0 in 2023, then plummeted by 129.97% to -$110000.0 in 2024, then skyrocketed by 993.64% to $983000.0 in 2025, then plummeted by 105.09% to -$50000.0 in 2026.
  • Per Business Quant, the three most recent readings for STAA's Cash from Financing Activities are -$50000.0 (Q1 2026), $983000.0 (Q3 2025), and -$4.5 million (Q2 2025).